Memantine kit is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store memantine hydrochloride tablets at 25°C (77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Memantine
- Brand
- Sold under the generic name
- Dosage form
- Kit
- Route
- Oral
- Packs
- 1 blister pack
- Manufacturer
- Actavis Pharma
- Origin register
- US FDA, United States
- Storage
- Store memantine hydrochloride tablets at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06DX01 Memantine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2015
- Identifiers
- RxCUI 996561, 996571, 996572DailyMed set ID 72973b46-f307-4a9e-8fb1-ad2cbccfd736NDC 0591-3900Application NDA021487
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 1 kit in 1 blister pack | 0591-3900-87 | Actavis Pharma | 1 April 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Memantine
Clinical summary
Memantine is a N-methyl-D-aspartate receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. It is available as tablets, extended-release capsules and oral solution. MedsAcross supplies Memantine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MemantineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- memantine hydrochloride prescribing information (Actavis Pharma) · U.S. National Library of Medicine, DailyMed
- Axura: European public assessment report (EPAR) · European Medicines Agency
- Ebixa: European public assessment report (EPAR) · European Medicines Agency
Need Memantine kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.